Back
Day Range
$52.41
$55.65
52-Week Range
$16.16
$56.30
Volume
322,262
50D / 200D Avg
$47.29
/
$38.36
Prev Close
$53.80
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 46.6 | 0.3 |
| P/B | 7.9 | 2.9 |
| ROE % | 17.8 | 3.7 |
| Net Margin % | 3.7 | 3.8 |
| Rev Growth 5Y % | 11.7 | 10.0 |
| D/E | 2.7 | 0.2 |
Analyst Price Target
Hold
$49.00
-11.7%
Forward P/E
17.8
Forward EPS
$3.03
EPS Growth (est.)
+0.0%
Est. Revenue
1.5 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$3.71
$3.68 – $3.74
|
1.6 B | 1 |
| FY2027 |
$3.37
$3.13 – $3.54
|
1.5 B | 3 |
| FY2026 |
$3.03
$2.98 – $3.07
|
1.5 B | 3 |
Key Takeaways
Revenue grew 11.68% annually over 5 years — strong growth
Earnings grew 1897.68% over the past year
ROE of 17.80% — decent returns on equity
Debt/Equity of 2.67 — high leverage
Generating 41.83M in free cash flow
P/E of 46.60 — premium valuation
Growth
Revenue Growth (5Y)
11.68%
Revenue (1Y)27.37%
Earnings (1Y)1897.68%
FCF Growth (3Y)N/A
Quality
Return on Equity
17.80%
ROIC7.91%
Net Margin3.72%
Op. Margin8.52%
Safety
Debt / Equity
2.67
Current Ratio2.76
Interest Coverage3.32
Valuation
P/E Ratio
46.60
P/B Ratio7.87
EV/EBITDA26.64
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 27.37% | Revenue Growth (3Y) | 15.13% |
| Earnings Growth (1Y) | 1897.68% | Earnings Growth (3Y) | 21.66% |
| Revenue Growth (5Y) | 11.68% | Earnings Growth (5Y) | -2.94% |
| Profitability | |||
| Revenue (TTM) | 1.30B | Net Income (TTM) | 48.26M |
| ROE | 17.80% | ROA | 3.55% |
| Gross Margin | 30.85% | Operating Margin | 8.52% |
| Net Margin | 3.72% | Free Cash Flow (TTM) | 41.83M |
| ROIC | 7.91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.67 | Current Ratio | 2.76 |
| Interest Coverage | 3.32 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 46.60 | P/B Ratio | 7.87 |
| P/S Ratio | 1.73 | PEG Ratio | 0.01 |
| EV/EBITDA | 26.64 | Dividend Yield | 0.02% |
| Market Cap | 2.25B | Enterprise Value | 2.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.30B | 1.02B | 977.89M | 942.26M | 833.35M |
| Net Income | 48.26M | 2.42M | 32.61M | 49.18M | 54.39M |
| EPS (Diluted) | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 |
| Gross Profit | 399.94M | 313.09M | 298.24M | 285.40M | 271.38M |
| Operating Income | 110.47M | 53.32M | 71.85M | 78.99M | 74.87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.36B | 982.18M | 971.40M | 931.70M | 841.33M |
| Total Liabilities | 1.08B | 725.54M | 688.89M | 669.26M | 602.80M |
| Shareholders' Equity | 285.68M | 256.64M | 282.51M | 262.44M | 238.53M |
| Total Debt | 761.55M | 525.46M | 509.97M | 470.48M | 426.71M |
| Cash & Equivalents | 68.04M | 70.61M | 41.28M | 74.25M | 50.21M |
| Current Assets | 810.61M | 601.00M | 585.72M | 566.23M | 498.91M |
| Current Liabilities | 293.47M | 204.15M | 176.00M | 190.83M | 164.12M |